Hyde Park Capital Announces Sale Of Trident Health Resources To Specialty Care

Hyde Park Capital Announces Sale Of Trident Health Resources To Specialty Care

Tampa, Florida – February 3, 2017 – Hyde Park Capital Advisors, LLC (“Hyde Park Capital”) is pleased to announce the sale of Trident Health Resources, Inc. (“Trident”) to Specialty Care (“Specialty Care”).  Trident provides outsourced perfusion services which is the staffing and provision of heart and lung machines and supplies to hospitals that perform open heart surgeries.  Hyde Park Capital served as the exclusive investment banker to Trident for this transaction.

Specialty Care CEO Melvin F. Hall, PhD, said, “I am thrilled to welcome the people of Trident to our team. They have built a tremendous reputation for the highest level of perfusion expertise based on a patient-first philosophy and an evidence-based approach to care. That powerful combination makes Trident an extremely valuable clinical partner.”

According to Trident CEO and President Ralph E. Jordan, who founded the company in 1988, “After growing this business from the ground up and taking great care to build a reputation for excellence and integrity, it was essential for me to choose a partner who would honor and sustain that legacy. I have complete confidence that Specialty Care is the right choice. Our clinicians will enjoy new professional development opportunities with a strong and stable company while also using Specialty Care’s robust benchmarking and evidence-based clinical standards to continually improve patient care.”

Ralph E. Jordan further commented, “Hyde Park Capital has a long history of guiding the negotiations on business transactions and satisfying customers’ objectives.   Selling my company after 30 years was momentous for me. I needed an investment bank I could trust to ensure a successful outcome.  I couldn’t be happier thanks to the Hyde Park team. The positive outcome was a direct result of the hard work and professionalism made on my behalf. Throughout all phases of the sale process right up until the closing, there was attention given to every aspect of the transaction.”

John M. McDonald, Senior Managing Director for Hyde Park Capital, said, “We have been good friends of Trident and Ralph for many years and have enjoyed watching this local and very entrepreneurial company grow rapidly and successfully.  It was an honor and a pleasure to represent Trident to the market and help consummate the sale of the company to such a high quality strategic buyer.”

About Trident Health Resources

Located on Florida’s West Coast in Dunedin, Florida, Trident is a Joint Commission certified premiere perfusion services staffing company that supports open heart programs nationally through leadership and staffing support.   Trident shares the mission of some of the finest hospitals to provide superior clinical care to the patient.  The company always strives to exceed expectations in patient care through quality processes and clinical expertise. Trident’s perfusion services are available on a contracted long-term or locum tenens basis. The company does more than “put a person behind a pump” or simply place certified staff as an employment agency might do. Trident’s role expands into the management of all the related functions of perfusion services on a 24/7, 365 days per year basis.  For more information, visit www.tridenthealth.com.

About SpecialtyCare

More than 13,500 physicians at 1,300 hospitals trust SpecialtyCare to help them achieve exceptional care outcomes, regulatory compliance, and financial results. With approximately 1,700 associates supporting over 375,000 procedures annually, we maintain SCOPE™, the SpecialtyCare Operative Procedural Registry, which is used to define standards, determine benchmarks, disseminate best practices, and foster innovations that improve patient outcomes, increase efficiencies, and minimize costs. SpecialtyCare is accredited and certified by The Joint Commission. By developing expertise beyond industry requirements, their customers can be certain they have the best partner for clinical excellence in perfusion, intraoperative neuromonitoring, autotransfusion, sterile processing management, surgical assist, and minimally invasive surgical support. SpecialtyCare is a portfolio company of American Securities LLC, a leading U.S. private equity firm. For more information, visit www.specialtycare.net.

About Hyde Park Capital

Hyde Park Capital is an institutionally focused investment banking firm specializing in mergers and acquisitions and private placements and serving the corporate finance needs of middle market public and private companies. Our principals have extensive investment banking experience executing merger & acquisition engagements, including purchase and sale of company assignments, recapitalizations, financial advisory, fairness opinions and raising growth capital and acquisition financing for companies, including equity, mezzanine and senior debt.  As one of the most active investment banking firms in the Southeast, our professionals have advised on more than 300 corporate investment banking transactions totaling more than $10 billion in transaction value.  We are headquartered in Tampa, Florida and are a member of FINRA and SIPC.  For additional information on Hyde Park Capital, visit www.hydeparkcapital.com or call (813) 383-0202.

Client Testimonials

"Hyde Park’s team guided us through the process, providing us with a number of high quality counter-parties, and supported us through the transaction structuring, negotiation and due diligence. We are very pleased with the outcome and excited for the future of DTS.”
Allen Ibaugh, Co-Founder and CEO of Data Transfer Solutions
“We enjoyed working with Hyde Park Capital and appreciated their M&A expertise in the technology services sector and their help on this important transaction.”
Chris Toepke, CEO of Trifecta
“We very much appreciated the assistance of Hyde Park Capital on this strategic acquisition for ITE. Their M&A experience was quite helpful to our team and the overall process and assured the deal was well executed and we got it closed on schedule.”
Scott Dols, CEO of Industrial Truck & Equipment, LLC
SEE ALL TESTIMONIALS